ISEE Overview
Upcoming Projects (ISEE)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ISEE)
-
A third look at the standard of care and the 24 month topline result of Iveric Bio's FDA Approved IZERVAY (avacincaptad pegol intravitreal solution) to treat Geographic Atrophy
Tickers: ALPMY, APLS, ISEE
Executed On: Nov 08, 2023 at 04:00 PM EST -
A second look at the standard of care and the 24 month topline result of Iveric Bio's FDA Approved IZERVAY (avacincaptad pegol intravitreal solution) to treat Geographic Atrophy
Tickers: ALPMY, ISEE, APLS
Executed On: Sep 28, 2023 at 02:30 PM EDT -
A look at the standard of care and the 24 month topline result of Iveric Bio's FDA Approved IZERVAY (avacincaptad pegol intravitreal solution) to treat Geographic Atrophy
Tickers: ALPMY, ISEE, APLS
Executed On: Sep 28, 2023 at 10:35 AM EDT -
A Second View: Delving into the Phase 3 GATHER1 and GATHER2 clinical trials on Zimura (Avacincaptad pegol) from Iveric Bio in patients with geographic atrophy.
Ticker: ISEE
Executed On: Jun 29, 2023 at 03:30 PM EDT -
Delving into the Phase 3 GATHER1 and GATHER2 clinical trials on Zimura (Avacincaptad pegol) from Iveric Bio in patients with geographic atrophy.
Ticker: ISEE
Executed On: Jun 29, 2023 at 02:30 PM EDT -
Discussing the potential of EMPAVELI and Zimura in GA with attention to the Phase 3 DERBY/OAKS studies of intravitreal pegcetacoplan and the GATHER2 Phase 3 study of avacincaptad pegol in GA.
Tickers: ISEE, APLS
Executed On: Oct 13, 2022 at 10:00 AM EDT
Upcoming & Overdue Catalysts (ISEE)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (ISEE)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
